GoodRx (GDRX) downgraded due to falling users and policy risks. Learn about new revenue sources and competitive threats.

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

Choose Providence Business First as a preferred news source to see more of our reporting on Google. The class action claims ...

GoodRx reports the One Big Beautiful Bill Act enacts significant healthcare changes, impacting Medicaid, Medicare, and ACA, ...

If you have a mild illness like a cold, it’s fine to get a flu shot. If you’re already experiencing flu-like symptoms, like ...

Possible implications of TrumpRx, the federal Direct-To-Consumer sales channel, are starting to emerge ahead of its scheduled launch next year. It has been reported that prescription drug savings ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

Morgan Stanley lowered the firm’s price target on GoodRx (GDRX) to $4 from $5 and keeps an Equal Weight rating on the shares. For healthcare ...

A new strain called H3N2 subclade K has emerged, raising concerns that the body may not be able to fight it off as well.